News – NEWBERRY, FL – June 11, 2021 Weight loss surgery improves or cures diseases, including type 2 diabetes, heart disease, high blood pressure, can lead to significant weight loss for many, but surgery is generally limited to those with severe obesity, which means about 75 : up to 100 kg overweight or body mass index (BMI) 35 և higher with obesity-related disease.
New research * presented at the American Metabolic Surgery Surgery (ASMBS) 2021 Annual Meeting, however, challenges these traditional patient selection criteria, finding that the same health-promoting benefits can be achieved by patients who lose weight. .
Researchers at the Brody Medical School at the University of Greenville in the University of Greenland have found that patients with a BMI between the ages of 30 and 35 who are considered to be grade 1 obese have lost up to 20% of their original BMIs և 45% more likely , to be their kind of remission. Two years after gastric bypass or gastrectomy, the two most common procedures for bariatric surgery. Patients with gastric bypass grafting had a twice as high risk of recurrence of hyperlipidemia as patients with TB (50% vs. 25%), and three years later had a 50% chance of having high blood pressure bypassing the stomach with a 50% chance. gastrectomy.
The real-world study included 566 gastric bypass patients և 730 patients with gastrectomy with an average BMI of 33. Both procedures reduce the size of the stomach and reduce hunger. Health outcomes were obtained from a database of health records that included patients from various US institutions.
“This study confirms the effectiveness of bariatric surgery in patients with grade 1 obesity in the real world. It suggests that earlier intervention should be considered for earlier disease,” said Maria Altieri, co-author of the study, a bariatric surgeon. Brody Medical School, University of Carolina.
Most health insurers still follow the guidelines developed by the National Institutes of Health (NIH) in 1991, when bariatric surgery was performed only as an open procedure. They note that weight loss surgery should be considered for patients with a BMI> 40, or “in some cases” for patients with a BMI between the ages of 35 and 40 who also have serious obesity-related illnesses, such as type 2 diabetes or high blood pressure. pressure. BMI is a measure of body fat based on a person’s weight in relation to their height.
“Evidence continues to grow that people with lower BMIs may benefit from metabolic bariatric surgery,” says Matthew M. . “This guarantees a reassessment of patient selection criteria so that everyone who can benefit can access this life-saving treatment.”
In its position published in 2018, ASMBS revised the 2012 His recommendation և advised individuals with a BMI between the ages of 30 and 35 to offer bariatric surgery as an option after a failure of non-surgical treatment, although he noted that current non-surgical treatments “are often ineffective in achieving major, long-term weight loss and joint disease.”
In addition, in 2016, 45 professional companies, including the American Diabetes Association, issued a joint statement that metabolic surgery should be considered in patients with type 2 diabetes և BMI 30.0-34.9 if hyperglycemia is poorly controlled despite oral or optimal treatment with injectable drugs.
Abol has been shown to be the most effective “long-term” treatment for severe / obese metabolic / bariatric surgery, leading to significant weight loss, resolution or improvement in diabetes, heart disease, sleep apnea, and many other diseases. The safety profile of laparoscopic bariatric surgery is comparable to that of the safest and most common surgeries in the United States, including gallbladder surgery, appendectomy, and knee replacement.
According to the ASMBS, about 256,000 bariatric surgeries were performed in 2019, representing less than 1% of the currently eligible surgical population at BMI. Nearly 60% had a gastrectomy, an increasingly common procedure that involved removing most of the stomach and leaving the rest in the tube or tube, limiting the amount of food stored in it. About 18% of the procedures were gastric bypass.
The CDC reports that 42.4% of adults in the United States were obese in 2017-2018. Another 9.2% had severe obesity. Obesity is associated with more than 40 diseases, including type 2 diabetes, hypertension, heart disease, stroke, sleep apnea, osteoarthritis, and at least 13 different types of cancer.
ASMBS is the largest organization of bariatric surgeons in the country. It is a non-profit organization that works to advance the art and science of bariatric surgery, and is committed to educating medical professionals and the public about bariatric surgery as a treatment for obesity, as well as its risks and benefits. . It encourages its members to investigate, discover new advances in bariatric surgery, while maintaining a consistent exchange of experience and ideas, which can lead to improved surgical outcomes in patients with severe obesity. For more information, visit www.asmbs.org.
1: Weiner, RA և others. (2010): Indications և Metabolic Surgery և Principles. US National Library of Medicine. 81 (4) pp. 379-394. https://www.ncbi.nlm.nih.gov/pubmed/20361370:
2:Gastric bypass surgery is just as safe as regular surgery. Good health conditions. Cleveland Clinic. November 6, 2014. Available in October 2017 https://health.clevelandclinic.org/2014/11/gastric-bypass-is-as-safe-as-commonly-performed-surgeries/
4:Effectiveness of Bariatric Surgery և Risks. Updated Systematic Review և Meta-Analysis, 2003-2012. Access: https://jamanetwork.com/journals/jamasurgery/fullarticle/1790378
5:Steele CB, Thomas CC, Henley SJ et al. Vital signs. Trends in Cancer Overweight and Obesity – United States, 2005–2014. MMWR Morb Mortal Wkly Rep 2017; 66: 1052–1058: DOI: http://dx.doi.org/10.15585/mmwr.mm6639e1:
6:Disease Control and Prevention Centers. (2015) Health effects of overweight and obesity. Available at https://www.cdc.gov/healthyweight/effects/index.html
* “Results in patients undergoing bariatric surgery with type I obesity”
Saturday 6.12.21 Paper Session 3:
Presentation: 15:23 – 15:28 PM
Discussion: 15:28 – 15:31 PM
Host: Maria Altieri [email protected], co-authored by Eric Demaria